Daptomycin for endocarditis and/or bacteraemia: a systematic review of the experimental and clinical evidence

ME Falagas, KP Giannopoulou, F Ntziora… - Journal of …, 2007 - academic.oup.com
Background Endocarditis and bacteraemia are devastating infections with high mortality.
Gram-positive cocci are the most commonly isolated pathogens. In an era of multidrug …

[PDF][PDF] Daptomycin for endocarditis and/or bacteraemia: a systematic review of the experimental and clinical evidence

ME Falagas, KP Giannopoulou, F Ntziora… - Journal of …, 2007 - scholar.archive.org
Background: Endocarditis and bacteraemia are devastating infections with high mortality.
Grampositive cocci are the most commonly isolated pathogens. In an era of multidrug …

Daptomycin for endocarditis and/or bacteraemia: a systematic review of the experimental and clinical evidence.

ME Falagas, KP Giannopoulou… - Journal of …, 2007 - search.ebscohost.com
Background Endocarditis and bacteraemia are devastating infections with high mortality.
Gram-positive cocci are the most commonly isolated pathogens. In an era of multidrug …

Daptomycin for endocarditis and/or bacteraemia: a systematic review of the experimental and clinical evidence.

ME Falagas, KP Giannopoulou, F Ntziora… - The Journal of …, 2007 - europepmc.org
Background Endocarditis and bacteraemia are devastating infections with high mortality.
Gram-positive cocci are the most commonly isolated pathogens. In an era of multidrug …

Daptomycin for endocarditis and/or bacteraemia: a systematic review of the experimental and clinical evidence

ME Falagas, KP Giannopoulou… - The Journal of …, 2007 - pubmed.ncbi.nlm.nih.gov
Background Endocarditis and bacteraemia are devastating infections with high mortality.
Gram-positive cocci are the most commonly isolated pathogens. In an era of multidrug …

[PDF][PDF] Daptomycin for endocarditis and/or bacteraemia: a systematic review of the experimental and clinical evidence

ME Falagas, KP Giannopoulou, F Ntziora… - Journal of …, 2007 - academia.edu
Background: Endocarditis and bacteraemia are devastating infections with high mortality.
Grampositive cocci are the most commonly isolated pathogens. In an era of multidrug …

[HTML][HTML] Daptomycin for endocarditis and/or bacteraemia: a systematic review of the experimental and clinical evidence

ME Falagas, KP Giannopoulou, F Ntziora… - Database of Abstracts …, 2007 - ncbi.nlm.nih.gov
This review evaluated the effectiveness of daptomycin in the treatment of patients with Gram-
positive cocci endocarditis and/or bacteraemia. It concluded that, although daptomycin …

[引用][C] Daptomycin for endocarditis and/or bacteraemia: a systematic review of the experimental and clinical evidence

ME FALAGAS, KP GIANNOPOULOU… - Journal of …, 2007 - pascal-francis.inist.fr
Daptomycin for endocarditis and/or bacteraemia : a systematic review of the experimental
and clinical evidence CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

[PDF][PDF] Daptomycin for endocarditis and/or bacteraemia: a systematic review of the experimental and clinical evidence

ME Falagas, KP Giannopoulou, F Ntziora, KZ Vardakas - 2007 - Citeseer
Background: Endocarditis and bacteraemia are devastating infections with high mortality.
Grampositive cocci are the most commonly isolated pathogens. In an era of multidrug …

Daptomycin for endocarditis and/or bacteraemia: a systematic review of the experimental and clinical evidence.

ME Falagas, KP Giannopoulou, F Ntziora, KZ Vardakas - 2007 - cabidigitallibrary.org
Background: Endocarditis and bacteraemia are devastating infections with high mortality.
Gram-positive cocci are the most commonly isolated pathogens. In an era of multidrug …